Phospholipase C-γ2 (PLC-γ2) plays an important role in B-cell signaling. Phosphorylation of various tyrosine residues of PLC-γ2 has been implicated in regulation of its lipase activity. With the use of antibodies specific for each of the putative phosphorylation sites, we have now shown that PLC-γ2 is 
completely, responsible for phosphorylation of Y753 and Y759, whereas phosphorylation of Y1217 is independent of Btk. Finally, phosphorylation of Y1217 and that of Y753 and Y759 occurred on different PLC-γ2 molecules.
The phospholipase C-γ (PLC-γ) isozymes PLC-γ1 and PLC-γ2 are 50% identical in amino acid sequence and share the same domain organization, including the arrangement of an NH 2 -terminal pleckstrin homology (PH) domain, catalytic X and Y domains, two Src homology 2 (SH2) domains, and one SH3 domain (Fig. 1A) . PLC-γ1 is expressed in all tissues examined, whereas the expression of PLC-γ2 is largely restricted to a subset of cells of the hematopoietic lineage (4, 34, 50) . Genetic evidence suggests that the functions of the two isozymes may not overlap. Targeted disruption of the PLC-γ1 gene thus results in embryonic death in mice (22) , whereas deficiency of PLC-γ2 in mice is not lethal but manifests developmental abnormalities in B cells with consequent severe immunodeficiency as well as dysfunction of platelets and mast cells (48).
Both PLC-γ1 and PLC-γ2 are activated by tyrosine phosphorylation. An essential step in the activation of PLC-γ1 is phosphorylation of tyrosine 783 (Y783), which is induced by stimulation of receptors (such as those for platelet-derived growth factor [PDGF] or epidermal growth factor [EGF]) with intrinsic protein tyrosine kinase (PTK) activity or of receptors (such as B-or Tcell antigen receptors) that are linked to the activation of nonreceptor PTKs (4, 34, 50) . PLC-γ1 may be additionally phosphorylated on Y771 and Y1253.
The function of phosphorylation on Y771 or on Y1253, which is not required for induction of the lipase activity of PLC-γ1, is thus far unknown. PLC-γ1 phosphorylation on Y1253 occurs substantially in growth factor-stimulated Phosphorylation on Y771 also occurs in growth factor-stimulated cells but to an extent much smaller than that apparent for Y783 and Y1253 phosphorylation (39) .
Given that PLC-γ2 is much more abundant than is PLC-γ1 in B cells and that it is an essential component in signaling of the B-cell antigen receptor (BCR), the mechanism of PLC-γ2 activation has been studied most extensively in these cells. The binding of antigen to the BCR induces the activation of Src family PTKs Lyn, Fyn, and Blk (27) , which results in phosphorylation of the cytoplasmic tails of the BCR components. These phosphorylated tails provide docking sites for the SH2 domains of the PTK Syk, and BCRassociated Syk then phosphorylates various adapter proteins. The adapter BLNK (B-cell linker protein; also known as SLP-65) appears particularly important for PLC-γ2 activation (23, 28) . Phosphorylated BLNK provides a scaffold for the assembly of a macromolecular complex that includes PLC-γ2
and Btk, a member of the Tec family of PTKs. Activated Syk also contributes to the production of phosphatidylinositol 3,4,5-trisphosphate (PIP 3 ) by activating phosphatidylinositol (PI) 3-kinase (11, 32, 38) . An important function of PIP 3 is to bind the PH domain of Btk, thereby facilitating recruitment of the kinase to the cell membrane, probably at lipid rafts. Tyrosine-phosphorylated BLNK and PIP 3 thus promote nucleation of a signaling complex known as a signalosome (12) ; formation of the signalosome concentrates PLC-γ2 in lipid rafts, where it is phosphorylated by colocalized nonreceptor PTKs and gains access to its substrate.
Engagement of the BCR results in the recruitment into the signalosome and consequent activation of members of three distinct families (Src, Syk, and Tec) of nonreceptor PTKs. All three types of PTKs are able to phosphorylate PLC-γ2 in vitro (29, 35, 49) . However, it is not clear which kinase (or kinases) is responsible for PLC-γ2 phosphorylation in B cells. Gene disruption of Lyn or Syk resulted in inhibition of BCR-induced phosphorylation of PLC-γ2 (45) . However, given that tyrosine phosphorylation of BLNK, production of PIP 3 , and activation of Btk all occur downstream of Lyn/Syk activation, whether or not PLC-γ2 is a direct substrate of Lyn or Syk in B cells is difficult to prove. PLC-γ2 has been proposed to be a substrate for Btk on the basis of the observations that the extent of BCR-induced tyrosine phosphorylation of PLC-γ2 was increased in a murine B-cell line that overexpresses Btk (10, 37) , and was substantially (but not completely) decreased in a chicken B-cell line (DT-40) deficient in Btk (44) . BCR stimulation also failed to induce the formation of inositol 1,4,5-trisphosphate (IP 3 We previously identified Y753 and Y759 as the sites of PLC-γ2 phosphorylation (31) . Subsequently, Rodriguez et al. (35) showed that phosphorylation of Y753 and Y759 is essential for the activation of PLC-γ2 by comparing the abilities of wild-type and Tyr→Phe double-mutant (Y753F/Y759F) forms of human PLC-γ2 to restore the Ca 2+ response to BCR stimulation in a derivative of DT-40 cells made deficient in PLC-γ2.
Immunoblot analysis with antibodies to tyrosine phosphate failed to detect phosphotyrosine residues in the Y753F/Y759F mutant immunoprecipitated from the BCR-stimulated cells, suggesting that Y753 and Y759 are the major sites of phosphorylation in stimulated B cells. In contrast, Watanabe et al. (49) proposed Y1197 and Y1217, in addition to Y753 and Y759, as sites of phosphorylation by Btk on the basis both of in vitro phosphorylation assays and of the observation that mutation of all four Tyr residues was necessary to eliminate completely the BCR-induced phosphorylation of human PLC-γ2 expressed in DT-40 cells.
We have now generated antibodies specific for PLC-γ2 phosphorylated on either Y753, Y759, Y1197, or Y1217 and have used these antibodies to study the BCR-induced phosphorylation of PLC-γ2.
MATERIALS AND METHODS

Materials and cells.
Convulxin was obtained from Sigma. PDGF-BB (rat, recombinant) was from R&D Systems. LY294002, α-cyano-β-hydroxy-β-methyl-N-(2,5-dibromophenyl)propenamide (LFM-A13), phorbol myristate acetate (PMA), bisindolylmaleimide X (BIM), and PP1 were from Calbiochem.
Ramos, an Epstein-Barr virus-negative Burkitt's lymphoma cell line (26) , and J.gamma1, a PLC-γ1-deficient derivative of the Jurkat E6 cell line (19) kindly provided by R. T. Abraham, were maintained in RPMI 1640 medium supplemented with 10% fetal bovine serum (FBS), penicillin (100 U/ml), and streptomycin (100 μg/ml). Null TV-1 cells, which were derived from PLC-γ1 −/− mouse embryonic fibroblasts (22) and were kindly provided by G. Carpenter, were maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% FBS, penicillin (100 U/ml), and streptomycin (100 μg/ml). Platelets were isolated as described previously (9), without aspirin treatment, from the blood of healthy volunteers with acid-citrate-dextrose as an anticoagulant.
Mouse spleens (5 to ~10 spleens combined for each preparation) were taken from anesthetized animals and dispersed through a nylon mesh to generate a single-cell suspension. After hemolysis by osmotic shock, splenocytes were washed and incubated with anti-CD43 and anti-Mac-1 antibodyconjugated magnetic microbeads (Miltenyi Biotec, Auburn, Calif.). Resting B cells were recovered in the flow-through fraction after separation with an AutoMacs magnetic cell sorter (Miltenyi Biotec) as suggested by the manufacturer.
Antibodies.
Antibodies to PLC-γ2 phosphorylated on Y753, Y759, Y1197, or Y1217 (antipY753, anti-pY759, anti-pY1197, and anti-pY1217, respectively) were prepared by injection of rabbits with the phosphorylated peptides INSL(pY) DVSR (corresponding to residues 749 to 757 of human PLC-γ2, with pY representing phosphorylated Tyr), VSRM(pY)VDPS (residues 755 to 763), EEEL(pY)SSSR (residues 1193 to 1201, with Cys 1200 replaced with Ser to avoid conjugation with hemocyanin through this residue), and QLFL(pY) DTHQ (residues 1213 to 1221), respectively. All peptides were acetylated at their NH 2 termini, had a Gly-Gly-Gly linker sequence followed by a Cysamide added to their COOH termini, and were conjugated with keyhole limpet hemocyanin via the SH group of the terminal Cys. Peptides were manufactured by BioSynthesis. Antisera were depleted of cross-reactive antibodies by incubation with the phosphorylated peptides not used as the antigen (for example, pY759, pY1197, and pY1217 peptides for anti-pY753) in order to prevent possible recognition of phosphorylated sites other than the target. Although specific antibodies are usually purified with the use of the immobilized peptide antigen (with the nonphosphorylated peptide for negative selection and then with the phosphorylated peptide for positive selection) (42), we found that this approach resulted in the loss of high-affinity antibodies for the pY753 and pY759 peptides as a result of difficulty in eluting them from the affinity gel.
Rabbit polyclonal anti-PLC-γ2 antibody (Q20) was obtained from Santa Cruz Anti-pY783 PLC-γ1 antibody was from Biosource/QCB.
Expression of PLC-γ2 mutants.
Point mutations that result in the substitution of phosphorylation site Tyr residues with Phe were introduced into human PLC-γ2 cDNA with the use of the pMT2 vector and a QuikChange site-directed mutagenesis kit (Stratagene). The coding sequences of the mutant and wild-type PLC-γ2 cDNAs were then transferred to the pSC11 vector for the production of recombinant vaccinia viruses (6) . Null TV-1 cells were exposed for 3 h to the resulting viruses and then cultured for 24 h in DMEM containing 1% FBS.
Cell stimulation, cell lysis, immunoprecipitation, and immunoblot analysis.
Stimulation of vaccinia virus-infected Null TV-1 cells and preparation of cell lysates were described elsewhere (39) . Ramos and Jurkat cells were harvested by centrifugation, washed twice, and resuspended in ice-cold RPMI 1640 supplemented with 25 mM HEPES-NaOH (pH 7.4) at a density of 5 × 10 7 cells/ml. Platelets were suspended in Tyrode's solution. The cells were equilibrated at 37°C for 10 min and then stimulated, after which 0.25 volume of ice-cold 5× lysis buffer [100 mM HEPES-NaOH (pH 7.4), 5%
Triton X-100, 1% sodium dodecyl sulate (SDS), 5 mM EGTA, 5 mM EDTA, 100 mM NaF, 5 mM sodium vanadate, 25-μg/ml leupeptin, 25-μg/ml aprotinin, 0.5 mM 4-(2-aminoethyl)benzenesulfonylfluoride] was added and the resulting mixture was incubated for 10 min on ice before centrifugation at 40,000 × g for 10 min at 4°C. The resulting supernatants (cell lysates) were subjected to SDS-polyacrylamide gel electrophoresis. The separated proteins were transferred electrophoretically to a piece of nitrocellulose membrane, which was then probed with appropriate antibodies. Bound antibodies were detected with alkaline phosphatase-conjugated secondary antibodies (KPL) and the chemiluminescent reagent CDP-Star (Tropix).
Images were captured and analyzed with a Kodak Image Station 440 equipped with a cooled charge-coupled device camera. 
RNAi.
For RNA interference (RNAi), a small interfering RNA (siRNA) that targets human Btk mRNA was based on nucleotides 895 to 913 relative to the translation start site (16) . Custom SMARTpool Plus siRNAs that target human Syk as well as a control RNA (Scramble) were supplied by Dharmacon. Cells were washed once with ice-cold phosphate-buffered saline, suspended in electroporation buffer (Amaxa) at a density of 10 8 cells/ml, and subjected to electroporation with siRNA (1 μM) with an Amaxa Nucleofector apparatus and a 2.0-mm electroporation cuvette.
Measurement of inositol phosphates.
Ramos cells were labeled for 36 h with myo-[2-3 H]inositol (2.5 μCi/ml) (Amersham) in inositol-free DMEM containing 2% FBS. After washing, the cells were suspended in DMEM containing 25 mM HEPES-NaOH (pH 7.4) at a density of 1 × 10 6 to 2 × 10 6 cells/ml and LiCl (20 mM) and test agents were added. The cells (100 μl) were equilibrated at 37°C for 10 min, stimulated, and then mixed with 9 volumes of 5% perchloric acid. The perchloric acid extracts of cells were centrifuged to remove debris, and the resulting supernatants were neutralized with 2 M KOH before analysis of [ 3 H] inositol phosphates by high-performance liquid chromatography (HPLC) on a Partisil SAX-10 ion-exchange column and with a Flo-One on-line radiometric detector (Packard), as described previously (39) .
HPLC analysis of PLC-γ2.
Ramos cell lysates (prepared from 4 × 10 8 cells) were mixed with 3 ml of packed heparin-Sepharose CL-6B (Amersham Pharmacia Biotech) that had been equilibrated with a solution containing 20 mM Tris-HCl (pH 8.0), 1 mM EDTA, and 1 mM EGTA. After incubation for 1 h at 4°C with rocking, the mixture was poured into a column and washed with equilibration buffer supplemented with 20 mM NaCl. The bound proteins were eluted with 5 ml of equilibration buffer supplemented with 0.5 M NaCl. The eluted proteins were diluted 10-fold with equilibration buffer and then subjected to fractionation by HPLC on a heparin-5PW column (7.5-mm inside diameter by 7.5 cm; TosoHaas) that had been equilibrated with the equilibration buffer.
Bound proteins were eluted with a linear gradient of NaCl (0 to 1 M) in the equilibration buffer over 50 min at a flow rate of 1 ml/min. Fractions were collected at 1-min intervals, and those containing PLC-γ2 were identified by immunoblot analysis.
RESULTS
Characterization of antibodies specific for phosphorylated PLC-γ2.
The four residues Y753, Y759, Y1197, and Y1217 of PLC-γ2 have been implicated as the sites of phosphorylation on the basis of evidence from various indirect experimental approaches (31, 35, 49) . Like Y771 and Y783 of PLC-γ1, Y753 and Y759 of PLC-γ2 are located in the linker region between the catalytic X and Y domains (Fig. 1A) . Alignment of the sequences of PLC-γ1 and PLC-γ2 reveals that Y759 of PLC-γ2 corresponds to Y783 of PLC-γ1 (Fig. 1B) . However, Y753 of PLC-γ2 aligns poorly with Y771 of PLC-γ1; it corresponds instead to Y775 of PLC-γ1, but there is no evidence that this site is phosphorylated. PLC-γ2 does not contain a Tyr residue corresponding to Y771 of PLC-γ1. The COOH-terminal regions of PLC-γ1 and PLC-γ2 share little sequence similarity; PLC-γ2 does not contain a Tyr residue corresponding to Y1253 of PLC-γ1, and, conversely, PLC-γ1 does not possess Tyr residues corresponding to Y1197 and Y1217 of PLC-γ2. Attempts to map the phosphorylation sites of PLC-γ2 molecules isolated from stimulated B cells have not been successful (35) , probably because the extent of phosphorylation is low in BCR-stimulated cells (see below).
To confirm the identity of the tyrosine phosphorylation sites of PLC-γ2 and to provide a means with which to monitor phosphorylation at each site quantitatively, we prepared rabbit polyclonal antibodies specific for PLC-γ2 phosphorylated on either Y753, Y759, Y1197, or Y1217. The specificity of these various antibodies was tested with PLC-γ1-deficient fibroblasts (Null 
Phosphorylation of PLC-γ2 in various cell types.
We next compared the patterns of PLC-γ2 phosphorylation among Ramos in the stimulated cells. The band detected in the unstimulated cells appeared not to be attributable to recognition of nonphosphorylated PLC-γ2, because the antibodies did not yield this band with unstimulated platelets or Null TV-1 cells. Even when the amount of unstimulated platelet lysate loaded onto the gel was increased so that the amount of PLC-γ2 was similar to that for the Ramos cell sample, no positive band was observed (Fig. 2B) . Furthermore, PLC-γ2 immunoprecipitated from unstimulated Ramos cells with anti-PLC-γ2 was equally reactive with anti-pY753 as was PLC-γ2 in the lysate, suggesting that the band was not due to an unknown lysate protein ( BCR-induced PLC-γ2 phosphorylation was also examined in mouse splenic B cells. Although the extents of phosphorylation were lower than those in Ramos cells, PLC-γ2 was phosphorylated on Y753, Y759, and Y1217 but not on Y1197, as in Ramos cells (Fig. 2C) . Constitutive phosphorylation of Y753 was also apparent in unstimulated splenic B cells. Faint bands seen in the blots with anti-pY759 and anti-pY1217 are likely due to a small fraction of cells activated during isolation from spleen (Fig. 2C) .
BCR-induced PLC-γ2 phosphorylation.
The stoichiometry of phosphorylation at each site of PLC-γ2 was studied in BCR-stimulated Ramos cells. To obtain fully phosphorylated PLC-γ2, we stimulated the cells with pervanadate. PLC-γ2 appeared maximally phosphorylated after this treatment at all sites; no further increase in the reactivity of each phospho-specific antibody was observed with higher concentrations of pervanadate or with longer incubation periods. In all five immunoblots with anti-PLC-γ2, anti-pY753, anti-pY759, anti-pY1197, or antipY1217, the PLC-γ2 bands obtained with the pervanadate-treated cells were sharper and migrated much more slowly than those obtained with untreated cells or those stimulated via the BCR (Fig. 3A) . These results strongly (Fig. 3A) or as a doublet ( Fig. 2A) , suggesting that pY753 is distributed among PLC-γ2 molecules with different states of overall phosphorylation. The PLC-γ2 band detected by anti-pY759 in stimulated cells was also broad, albeit less so than that detected by anti-pY753.
Phosphorylation on Y1197 was not detected in BCR-stimulated cells even in the presence of vanadate; this failure to detect phosphorylation on Y1197
was not due to insensitivity of anti-pY1197, given that the intensity of the PLC-γ2 band detected with anti-pY1197 was similar to those of the bands detected by the other phospho-specific antibodies when cells were treated with pervanadate.
In contrast to those detected by anti-pY753 or anti-pY759, the PLC-γ2 band detected by anti-pY1217 in stimulated cells was sharp. In response to BCR stimulation in the absence of vanadate, 1.5% of PLC-2 molecules were phosphorylated on Y1217 and 0.45 to 0.5% were probably phosphorylated on both Y753 and Y759 (phosphorylation of Y753 and Y759 appears to occur on the same molecules, as shown below). If molecules phosphorylated on Y753 and Y759 were also phosphorylated on Y1217, the immunoreactivity detected with anti-pY1217 would be expected to be resolved into two bands (one for the ~1% of PLC-γ2 monophosphorylated on Y1217 and the other for the 0.45 to 0.5% of the enzyme that is trisphosphorylated) or at least to appear as a broad band. The sharpness of this band thus argues against this possibility.
We attempted to investigate whether phosphorylation on Y753, Y759, and Y1217 is present in the same molecules by precipitating PLC-γ2 with one phospho-specific antibody and probing the precipitates with the other antibody. However, none of the three antibody preparations proved suitable for immunoprecipitation. We therefore took another approach. Ramos cells were left unstimulated or stimulated either with anti-IgM or with pervanadate, and the resultant cell lysates were then fractionated by HPLC on a heparin column with an NaCl gradient (Fig. 3B) . PLC-γ2 molecules derived from the resting cells peaked in fraction 14. This preparation consisted of mostly unphosphorylated protein but contained small amounts (~0.3%) of PLC-γ2 phosphorylated on Y753 (Fig. 3A) . Distribution of this Y753 monophosphorylated protein was indistinguishable from the bulk of unphosphorylated PLC-γ2 detected by anti-PLC-γ2 (Fig. 3Ba, control) , indicating that phosphorylation of Y753 alone had no effect on the behavior on the heparin column. When stimulated with anti-IgM in the presence of vanadate, 1 to ~1.5% of PLC-γ2 molecules were phosphorylated on each of three sites (Fig. 3A) . The HPLC analysis of the anti-IgM-stimulated sample revealed that phosphorylated PLC-γ2 molecules detected by anti-pY753 or by anti-pY759 peaked in fraction 18, whereas those detected by anti-pY1217 overlapped with PLC-γ2 molecules detected with anti-PLC-γ2 (Fig. 3Ba, α- IgM + V). This result indicates that the pool of PLC-γ2 molecules phosphorylated on Y1217 is different from that phosphorylated on Y753 and Y759. Phosphorylation on Y753 alone was insufficient to cause the shift from fraction 14 to fraction 18 (as seen with the resting cell samples), but the elution profiles of pY753-and pY759-containing molecules were similar, with both peaking in fraction 18. This finding, together with the finding that activation of PLC-γ2 requires phosphorylation on both Y753 and Y759, suggests that Y753 and Y759 are phosphorylated within the same molecules.
While the stimulation through the BCR could elicit tyrosine phosphorylation of only small fractions of PLC-γ2 molecules, the treatment with a high dose of pervanadate was able to induce phosphorylation of most, if not all, of them (Fig. 3A) . When the lysate of pervanadate-treated cells was subjected to the HPLC analysis, PLC-γ2 protein was indeed recovered in the fraction that peaked at 18, and almost no PLC-γ2 was detected in fraction 14 (Fig. 3Bb ).
This peak of protein detected by anti-PLC-γ2 overlapped with the profile detected with anti-pY759 (Fig. 3Bb) and with anti-pY753 or anti-pY1217 (not shown).
The time courses of phosphorylation of PLC-γ2 at each site were examined in Ramos cells stimulated with a saturating concentration of anti-IgM. The extent of phosphorylation was maximal within 1 min for Y753, Y759, and Y1217 (Fig. 4A) . The time courses for Y753 phosphorylation and Y759 phosphorylation were similar, whereas the extent of phosphorylation of Y1217 decreased at a slower rate. This result, together with the observation that vanadate enhanced BCR-induced phosphorylation at Y753 and Y759 but not that at Y1217, suggests that the linker region residues might be dephosphorylated by a PTP different from that responsible for dephosphorylation of the COOH-terminal residue. Stimulation of murine splenic B cells with anti-IgM yielded a pattern of PLC-γ2 phosphorylation similar to that obtained with Ramos cells (Fig. 4B) . PTKs that belong to the Src family, most notably Lyn, initiate BCR signaling by phosphorylating several components in the BCR. Syk is then recruited by the phosphorylated receptor chains and activated to phosphorylate many cellular substrates such as BLNK (28) . We tested the effect of PP1, an nhibitor of Src family kinases, on the phosphorylation of PLC-γ2 in Ramos cells. Phosphorylation of Y753, Y759, and Y1217 induced by anti-IgM was markedly inhibited by PP1 (Fig. 5A) . The higher-mobility band observed with anti-pY753, which corresponds to constitutively phosphorylated PLC-γ2 molecules, was resistant to PP1 under the experimental condition, however.
As expected, BCR-induced tyrosine phosphorylation of cellular proteins in general was inhibited by PP1, as revealed by immunoblot analysis with antiphosphotyrosine ( Fig. 5A) . Given the lack of specific pharmacological inhibitors of Syk family kinases, we used RNAi to deplete Ramos cells of Syk. It was necessary to transfect the cells with the Syk siRNA twice with an interval of 2 days to achieve a substantial reduction (~70%) in the extent of Syk expression 4 days after the initial transfection (Fig. 5B) . Depletion of Syk resulted in marked inhibition of BCR-induced phosphorylation of PLC-γ2 at all three sites (Fig. 5B) .
Again, the lower-mobility (more highly phosphorylated) band detected with anti-pY753 was more responsive to Syk depletion than was the higher- antiphosphotyrosine did not appear to be affected in these cells (10) . We evaluated the role of Btk in the phosphorylation of PLC-γ2 at each site by using PI 3-kinase inhibitors. Given that PIP 3 binding to Btk's PH domain is required to recruit Btk to plasma membranes where Btk phosphorylates its substrates, inhibition of PIP 3 synthesis is expected to block Btk function. At saturating concentrations of LY294002, an inhibitor of PI 3-kinase, BCRinduced phosphorylation of PLC-γ2 on Y753 and Y759 in Ramos cells was inhibited by ~60 to 70%, whereas that of Y1217 was minimally affected (Fig.   6A ). We also employed wortmannin, another potent PI 3-kinase inhibitor, and observed a similar result (Fig. 6B) .
As a measure of PI 3-kinase inhibition, phosphorylation of Akt on Thr 308 was monitored in parallel. Phosphorylation of Akt appeared much more sensitive to the PI 3-kinase inhibitors than was PLC-γ2 phosphorylation (Fig. 6B) .
The serine/threonine kinase Akt possesses a PH domain, which recognizes PIP 3 as well as PI(3,4)P 2 , and translocates to membranes upon cellular synthesis of these phosphoinositides. Akt is then phosphorylated on Thr 308
FIG. 6. Effects of inhibition or depletion of Btk on BCR-induced PLC-γ2 phosphorylation in Ramos cells. (A) Effect of LY294002 (LY) on PLC-γ2
phosphorylation. Ramos cells were treated for 10 min with vehicle or the indicated concentrations of (more ...) by PDK1 (3-phosphoinositide-dependent protein kinase 1) and on Ser 473 by another kinase, and both reactions also depend on PI(3,4)P 2 and/or PIP 3 (1).
Thus, a relatively small change in PI 3-kinase activity can have a more profound effect on Akt activation than on Btk activation. Alternatively, because intracellular concentration of PIP 3 is the net result of phosphorylation by PI 3-kinase and dephosphorylation by PTEN and because PIP 3 is not evenly distributed throughout the plasma membranes (14, 15, 18, 51) , Akt and Btk might be activated by different pools of PIP 3 , and the PIP 3 pool that promoted nucleation of the BCR signalsome of Btk, BLNK, PLC-γ2, etc., might be less sensitive to PI 3-kinase inhibition than the pool responsible for Akt activation. We also tested the effect of PI 3-kinase inhibitors in mouse splenic B cells. As observed in Ramos cells, LY 294002 (Fig. 6D) or wortmannin (not shown) caused a large, but incomplete, reduction in BCR-induced phosphorylation on Y753 and Y759 but not on Y1217.
Involvement of Btk was studied by treating Ramos cells with LFM-A13, a Btk
inhibitor rationally designed on the basis of the structure of the kinase (30) .
Similar to the PI 3-kinase inhibitors, LFM-A13 caused ~70% inhibition of PLC-γ2 phosphorylation on Y753 and Y759 without affecting Y1217 phosphorylation (Fig. 6C) . LFM-A13 did not alter Akt phosphorylation on Thr 308 , however. The actions of LY 294002 and LFM-A13 appeared to be selective even at the high concentrations used, given that the overall pattern of BCR-induced tyrosine phosphorylation was not affected (Fig. 6E) . These results suggest that phosphorylation of Y753 and Y759 residues largely depends on Btk, whereas phosphorylation of Y1217 is independent of Btk.
Given that the phosphorylation of the linker region residues was not completely blocked by saturating doses of LY294002, wortmannin, or LFM-A13, however, PTKs other than Tec family members likely participate directly in the phosphorylation of these two sites.
The role of Btk was also studied by RNAi. Three days after transfection of Ramos cells with a Btk-specific siRNA, the expression of Btk was reduced to 31% ± 4% (mean ± standard error; n = 4) of that apparent in control cells (Fig. 6F) . The BCR-induced phosphorylation of PLC-γ2 on Y753 or Y759 was reduced by 55% ± 9% and 63% ± 2%, respectively, in these Btkdepleted cells, whereas the level of Y1217 phosphorylation was 99% ± 5% of that in control cells (Fig. 6F) . These data thus provide further support for (Fig.6F) .
the notion that BCR-induced phosphorylation of PLC-γ2 is achieved by both Btk-dependent and Btk-independent mechanisms.
Effects of changes in PKC activity on the phosphorylation and activation of PLC-γ2.
Protein kinase C (PKC) down-regulates Btk activity by directly phosphorylating Btk on Ser 180 (25) . We tested the effects of the PKC inhibitor BIM and the PKC activator phorbol myristate acetate (PMA) on PLC-γ2 phosphorylation in Ramos cells (Fig. 7A) . (Fig. 7C) . BIM promoted the BCR-induced production of inositol phosphates (Fig. 7C) , indicating that the activation of PLC-γ2 is dependent on the phosphorylation of Y753 and Y759 but is not affected by 
Role of PI 3-kinase in BCR-induced PLC-γ2 activation.
Activation of PI 3-kinase has been considered a requirement for BCRinduced PLC-γ2 activation, and this requirement has been attributed to the role of PIP 3 in the membrane recruitment of Btk (12) . Our results now indicate that the recruited Btk activates PLC-γ2 by phosphorylating it on Y753/Y759 (Fig. 6 and 7) . We have shown that PIP 3 does not affect growth factor-induced PLC-γ1 phosphorylation on the critical residue Y783 but serves as an activating factor for the Y783-phosphorylated enzyme (39).
We therefore investigated whether tyrosine-phosphorylated PLC-γ2 is also activated by PIP 3 .
LY294002 inhibited the BCR-induced PLC activation in Ramos cells in a dose-dependent manner (Fig. 8A) . At 30 or 100 μM, LY294002 inhibited PLC activity by 70 and 80%, respectively, while the same concentrations of this drug reduced the extent of BCR-induced PLC-γ2 phosphorylation on Y753/Y759 by 40 and 60%, respectively (Fig. 5A) . PIP 3 thus appears to act both at the level of Btk to up-regulate PLC-γ2 phosphorylation and as an activator of the lipase activity of the phosphorylated PLC-γ2.
To provide further support for this conclusion, we examined the effects of Btk RNAi followed by treatment with LY294002 (Fig. 8B) RNAi alone. These results are thus consistent with a dual role for PIP 3 in BCR-induced PLC-γ2 activation.
Given that Ramos cells express PLC-γ1 and that BCR engagement induces phosphorylation of this isozyme on the critical residue Y783 (39), it was important to assess the possible contribution of PLC-γ1 to BCR-induced PLC activity. The amount of PLC-γ1 in Ramos cells is only one-fourth of that of PLC-γ2; the BCR-induced phosphorylation of PLC-γ1 is similar to that of PLC-γ2 in terms of kinetics and stoichiometry; and the two isozymes exhibit similar specific activities in vitro (data not shown). Furthermore, LY294002
and Btk RNAi each inhibited PLC-γ1 phosphorylation on Y783 (Fig. 8B) .
On the basis of these observations, the presence of PLC-γ1 in Ramos cells does not appear to undermine the conclusion that PIP 3 plays a dual role in BCR-induced PLC-γ2 activation.
CD19 is a BCR-associated coreceptor that functions as an enhancer of BCR signaling. This transmembrane protein contains two Tyr residues that are phosphorylated in response to cross-linking of CD19 molecules and then serve as binding sites for the SH2 domains of the p85 regulatory subunit of PI 3-kinase (3, 47) . This interaction with CD19 results in the activation of PI 3-kinase. We tested whether additional stimulation of PI 3-kinase via CD19 would enhance BCR-induced PLC activation. Costimulation of Ramos cells with anti-IgM and anti-CD19 resulted in a greater accumulation of inositol phosphates than that induced by anti-IgM alone (Fig. 8C) . Although CD19 stimulation alone has previously been shown to induce Btk activation and subsequent PLC-γ2 phosphorylation in human and mouse B cells (5, 13) , it induced neither measurable PLC-γ2 phosphorylation on Y759 nor inositol phosphate production under our experimental conditions (Fig. 8C) . The extent of costimulation-induced phosphorylation of PLC-γ2 on Y759 did not differ from that induced by BCR engagement alone. The enhancement of PIP 3 production induced by CD19 stimulation thus appeared to augment the lipase activity of PLC-γ2 (likely that of PLC-γ1 also) without affecting the state of PLC-γ2 phosphorylation in BCR-stimulated cells.
DISCUSSION
Identification of phosphorylation sites of PLC-γ2.
We have prepared and established the specificity of antibodies that recognize individual tyrosine phosphorylation sites of PLC-γ2. Studies with these antibodies revealed that engagement of the BCR induces phosphorylation of endogenous PLC-γ2 on Y753, Y759, and Y1217 in mammalian B-cell preparations. We previously identified Y753 and Y759 as the sites of phosphorylation of PLC-γ2 in BCR-stimulated Ramos cells by two-dimensional mapping of tryptic peptides followed by phosphoamino acid analysis; we failed, however, to detect a pY1217-containing peptide by this approach, possibly because pY1217 was distributed among several tryptic peptides as a result of partial digestion (three consecutive Arg residues form potential trypsin cleavage sites that would generate multiple pY1217- In contrast, Btk appears to phosphorylate certain residues of PLC-γ2 directly.
Maximal inhibition of Btk function by LY294002, wortmannin, or LFM-A13 resulted in 60 to 70% inhibition of PLC-γ2 phosphorylation on Y753 and Y759 without an effect on that of Y1217. Moreover, RNAi-mediated depletion of Btk by 70% and inhibition of the remaining enzyme molecules with a saturating concentration of LY294002 did not reduce the extent of phosphorylation of the linker region residues by more than 60 to 70% and did not affect the extent of Y1217 phosphorylation. These results indicate that Btk is the kinase responsible for the phosphorylation of >60% of PLC-γ2 molecules on Y753 and Y759, but that another kinase (or kinases) also phosphorylates these linker region residues. Phosphorylation of Y1217 appeared to be fully independent of Btk, though an in vitro study by Watanabe et al. (49) suggested this residue was a preferred Btk site. Chiu et al. (7) recently showed that Btk and PLC-γ2 must assemble on the same BLNK molecules to achieve functional Ca 2+ signaling. It is thus possible that PLC-γ2 molecules either recruited to the signalosome but not bound to Btkoccupied BLNK or recruited by some other means might be phosphorylated by other kinases such as Lyn or Syk.
Although we used PI 3-kinase inhibitors to downregulate Btk function, the mechanism by which this is achieved is not clear. There is a report suggesting that the tyrosine phosphorylation and activation of Btk are not affected by the absence of PI 3-kinase (43) . Nevertheless, a large body of evidence including our present study supports the involvement of PI 3-kinase in PLC-γ2 activation (8, 24). Therefore it is a possibility that PIP 3 might be required for the proper localization of Btk (likely in the BCR signalsome) necessary for PLC-γ2 phosphorylation but not for the activation of Btk via tyrosine phosphorylation.
Immortalized cell lines established from B cells of XLA patients manifest marked impairment of BCR-induced IP 3 production and Ca 2+ signaling, whereas the extent of BCR-induced tyrosine phosphorylation of PLC-γ2 in these cells was indistinguishable from that in wild-type B cells (10) . These results can now be explained by our finding that the Tyr residues essential for PLC-γ2 activation are minor sites of phosphorylation. The sum of pY753 and pY759 thus constituted only ~40% of total phosphorylated Tyr residues in PLC-γ2 in stimulated Ramos cells, and this percentage was further decreased to ~25% in cells in which Btk function was fully inhibited.
Moreover, given that phosphorylation of Y753 and of Y759 decayed faster than did that of Y1217, the percentage would be even smaller if the samples were not prepared at the peak time. It is thus likely that the level of BCRinduced tyrosine phosphorylation of PLC-γ2 in XLA B cells could be less than that in normal human B cells but that the difference would not be sufficiently large to be detected with antibodies to tyrosine phosphate.
Feedback inhibition of PLC-γ2 through Btk-dependent phosphorylation.
The activity of Btk is inhibited as a result of phosphorylation of the enzyme by PKC (25) , suggesting the existence of a link between PKC activation and PLC-γ2 phosphorylation on Y753 and Y759. Indeed, activation of PKC by PMA attenuated the BCR-induced phosphorylation of these two residues of PLC-γ2 without affecting that of Y1217. Conversely, inhibition of PKC by BIM augmented the BCR-induced phosphorylation of Y753 and Y759 without altering that of Y1217. Consistent with these observations, the BCR-induced production of inositol phosphates was also increased in cells exposed to Activation of both PLC-γ1 and PLC-γ2 is enhanced by PIP 3 , but the corresponding modes of action of this lipid might be cell type dependent. Whereas in immunoreceptor signaling PIP 3 promotes the activation of PLC-γ by enhancing both its tyrosine phosphorylation by Tec family PTKs (38, 46) and the catalytic activity of the resulting phosphorylated enzyme (this study),
